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1. Introduction 
The cellular signaling pathways that respond to Wnts control numerous processes ranging 
from gastrulation to aging and govern cell fate determination and patterning (Clevers, 2006). 
Wnt signaling abnormalities often lead to developmental disorders and lethal malignancies. In 
melanoma aberrant activation of Wnt signaling is often observed. Wnt signaling pathway is a 
very complex process. Its ligands, called Wnts, can signal via several pathways referred to as 
the canonical Wnt signaling and two noncanonical Wnt signaling pathways. According to the 
modern view, the canonical Wnt signaling branch is predominately involved in control of 
proliferation and differentiation acting at a transcriptional level, whereas the noncanonical 
ones affect cell motility and cytoskeletal rearrangements. In the case of melanoma, the 
canonical and the noncanonical Wnt pathways can play opposite roles. The noncanonical Wnt 
cascade promotes metastasis. Overexpression of Wnt5a correlates with a poor prognosis for 
patients. The canonical Wnt cascade has long been considered as fully oncogenic. However, a 
lot of data confirms that it can act as a tumor suppressor by promoting cell differentiation. 
2. Wnt proteins and their interactions 
Wnt genes were identified both in vertebrates and invertebrates whereas plants, unicellular 
eukaryotes and prokaryotes appear to lack them (Miller, 2001). In humans, the Wnt family 
encompasses 19 members. All of them are defined by sequence homology rather than by 
functional properties (Wnt homepage). Wnt genes encode highly modified glycoproteins of 
38-43 kDa that have typical features of the secreted growth factors, including a hydrophobic 
signal sequence, lack of transmembrane domains, an N-glycosilation site and a sustained 
spacing of conserved cysteine residues (McMahon, 1992). It is considered that 
posttranslational lipid modifications are essential for the Wnt function. Treatment of Wnts 
with the acylprotein thioesterase that removes palmitates leads to both hydropathy and 
signaling activity reduction (Willert et al., 2003). Moreover, mutations that prevent 
palmitoylation of cysteine residues in Wnt1, Wnt3a, Wnt5a result in significant decrease of 
their biological activity, presumably due to inability to bind Frizzled (Fz) receptors. These 
mutations do not affect secretion. In contrast, a mutation of the conserved serine in Wnt3a 
abrogates palmitoleic acid addition and blocks secretion. Considering these observations, it 
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is believed that the palmitoleic acid modification is required for secretion, whereas the 
palmitate modification is critical for receptor binding (Cadigan & Peifer, 2009). 
Complexity of the Wnt signaling is greatly enhanced by abundance of potential receptors. 
There are several groups of receptor molecules that can bind Wnts. The first group found to 
transduce the Wnt signal is the Frizzled (Fz) receptor family. The Fz proteins were identified 
both in vertebrates and invertebrates. In human and mice, the Fz family includes ten members 
(Wnt homepage). It is believed that Fz proteins are the real G-protein-coupled receptors that 
can activate the heterotrimeric G-protein to transmit signal from Wnts. Like typical GPCR, 
they have seven hydrophobic transmembrane domains, glycosylation and phosphorylation 
sites for cyclic AMP-dependent protein kinase (PKA), protein kinase C (PKC) and casein 
kinase 2 (CK2), and are able to form homomeric and heteromeric complexes with other 
members of the Fz family. However, there are several differences between the Fz receptors and 
other GPCRs. The Fz receptors lack two conserved motifs, Asp-Arg-Tyr and Asn-Pro-X-X-Tyr. 
The Asp-Arg-Tyr motif is located in the second intracellular loop of several GPCRs and is 
crucial for G protein coupling. The Asn-Pro-X-X-Tyr motif is present at the end of the seventh 
transmembrane segment of GPCRs (Angers & Moon, 2009). The classical Fz receptor consists 
of a long highly glycosilated N-terminal extension, that is positioned outside of the cell, seven 
transmembrane domains and a short cytoplasmic tail. An amino terminal region called a 
cysteine-rich domain (CRD) is intended for the direct Wnt binding. The carboxyl terminus 
contains a consensus PDZ domain-binding motif (S/T-X-V) that is important for interaction 
with cytoplasmic proteins (Miller, 2001). Wnt/Fz combination at the surface of the cell 
determinates the type of G-protein subunits to be utilized and the kind of cellular response to 
occur (Liu et al., 1999; Malbon et al., 2001). 
In addition to the Fz receptors, Wnt can bind to molecules of the low density lipoprotein 
(LDL) receptor-related protein (LRP) family. The Wnt-LRP coupling is considered to induce 
or stabilize the formation of the Fz-LRP-Wnt ternary complex. Wnts have a low affinity to 
LRP, as compared to Fz, so there is an idea that the coupling occurs between LRP and the 
Wnt–Fz complex (Tamai et al., 2000). Two members of the vertebrate LRP family, LRP5 and 
LRP6, are able to bind Wnts. The LRP6 mutant mice phenotype resembles defects caused by 
several individual Wnt genes deficiency (Pinson et al., 2000). LRP overexpression in Xenopus 
leads to activation of the Wnt signaling (Tamai et al., 2000). Moreover, binding of some 
extracellular inhibitors to LRP leads to abrogation of the Wnt signaling transduction (Itasaki 
et al., 2003; Glinka et al., 1998). Unlike to the Fz receptors, LRP6 is a single-pass 
transmembrane protein. It has a highly modular structure consisting of the extracellular 
domain (ECD) that mediates LRP6-ligand interactions, and the intracellular domain (ICD) 
that transduces extracellular signals to cytoplasmic effectors. ECD contains the extracellular 
proteins binding YWTD domains, EGF-like repeats, and LDL repeats. ECD is supposed to 
act as an autoinhibitory signal, since LRP6 lacking the ECD can constitutively activate the 
Wnt pathway. In contrast, the ICD domain is sufficient for the activation of the Wnt 
signalling pathway. The overexpression of the isolated ICD induces constitutive activation 
of the canonical Wnt signaling. The ICD domain is rich in proline, serine, and threonine and 
has a conserved PPSPXS motif critical for its function (Niehrs & Shen, 2010). 
Repertoire of the Wnt receptor molecules is broader than that of the Fz and LRP proteins. 
The Wnt ligands can also signal through alternative receptors, structurally related homologs 
Ror1 and Ror2 that belong to the receptor tyrosine kinase (RTK) superfamily, and Ryk that 
is an atypical tyrosine kinase receptor. Transgenic mice with the Ror2 loss-of-function 
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mutations demonstrate very similar phenotype to mice with the Wnt5a depletion (Oishi et 
al., 1999). Ror2 contains extracellular Fz-like cysteine-rich domains (CRDs), membrane-
proximal Kringle domains and immunoglobulin (Ig)-like domains. While CRDs and the Ig-
like domains participate in ligand binding, function of the Kringle domains is still unclear. 
However, it is assumed that the Kringle domains in Ror act as recognition modules for 
binding of the Wnt regulatory proteins (Minami et al., 2010). Another receptor molecule Ryk 
is thought to mediate the Wnt signaling. Unlike to Ror2, Ryk is an atypical Tyr kinase 
receptor. It lacks kinase activity due to amino acid substitutions in the evolutionarily 
conserved residues of the intracellular kinase domains (Halford et al., 1999; Hovens et al., 
1992). In addition to the intracellular kinase domain, Ryk contains a single transmembrane 
domain and an extracellular Wnt inhibitory factor (WIF) domain. The last one mediates 
binding of various Wnt ligands (Halford & Stacker, 2001). The choice of a ligand for 
interaction is rather controversial. According to different data, Ryk can bind both canonical 
and noncanonical Wnts. The physical interaction between Ryk and Wnt1 and Wnt3a with 
subsequent activation of the canonical Wnt signaling was demonstrated in the HEK293T 
cells (Lu et al., 2004). On the contrary, the noncanonical Wnt5a serves as a binding partner 
for Ryk in the Wnt5a-mediated axon guidance (Keeble et al., 2006). 
To complete the description of the Wnt-interacting partners, a special group of proteins that 
can bind Wnt ligands but unable to participate in signal transduction should be mentioned. 
These proteins act as inhibitors blocking the Wnt functional activity. The soluble Frizzled-
Related Proteins (sFRPs) represent a typical example of the extracellular Wnt inhibitors. 
They bind to Wnt proteins preventing them from coupling with their receptors. sFRPs are 
able to block both canonical and noncanonical Wnt signaling pathway. Another soluble Wnt 
inhibitor is called WIF-1 (Wnt inhibitory factor). Unlike to sFRPs, it does not contain a CRD 
domain. However, it can bind to Wnts through a unique domain that is similar to 
extracellular region of the Ryk receptors (Patthy, 2000).  
Another group of the Wnt signaling inhibitors consists of secreted Wnt antagonists. The 
Dickkopf (Dkk) family of the Wnt antagonists inhibits the Wnt signaling by direct binding to 
LRP5/6 (Glinka et al.,1998). It is considered that Dkk can form a ternary complex with 
LRP5/6 and a single-pass transmembrane receptor Kremen-1 in order to promote LRP5/6 
internalization with subsequent inactivation of the Wnt signaling (Mao et al., 2002). Binding 
of LRP by soluble Wnt signaling inhibitors is not a unique feature of Dkk. Some other 
secreted Wnt inhibitors (Wise and SOST) use the same mechanism (Itasaki et al., 2003; 
Semenov et al., 2005). 
Availability of different receptors, co-receptors and inhibitors create cellular context. An effect 
of the Wnt signaling pathway depends not on the Wnt ligand itself, but on the Wnt ligand in 
the cellular context. The same Wnt ligand can activate different Wnt signaling branches, and 
classification of Wnt ligands based on a type of Wnt signaling activated seems artificial.  
2.1 Different branches of the Wnt signaling 
The Wnt signaling is commonly considered as a combination of at least three different 
signaling branches: the ǃ-catenin pathway, the Wnt/Ca2+ pathway and the planar cell 
polarity (PCP) pathway. There is evidence of significant crosstalk between them. 
2.1.1 The canonical Wnt signaling pathway 
The canonical Wnt signaling pathway, or the ǃ-catenin pathway, was the first Wnt signaling 
discovered. It participates in multiple biological processes including embryogenesis, cell 
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proliferation and differentiation in adults, stem cell renewal in multiple tissues 
(hematopoietic, epidermal, and intestinal) and tumorigenesis (Clevers, 2006). A lot of 
growth genes (c-myc, cyclin D1, PPARδ) are under control of this signaling (He et al., 1998, 
1999; Tetsu & McCormick, 1999). Other target genes include the matrix metalloproteinase, 
fibronectin and the transcription factors AP-1, c-jun and fra1 (Brabletz et al., 1999; Gradl et 
al., 1999; Mann et al., 1999). The canonical Wnt signaling pathway can be activated by Wnts, 
such as Wnt1, Wn3a and Wnt8. In the absence of Wnts, concentration of the cytoplasmic ǃ-
catenin is maintained at a low level by a special destruction complex. The destruction 
complex consists of the scaffolding proteins Axin and APC (adenomatous polyposis coli), 
GSK3ǃ (glycogen synthase kinase 3ǃ), CKI (casein kinase I), PP2A (protein phosphatase 2A) 
and, probably, ubiquitin ligase ǃ-TrCP. When the destruction complex is active, ǃ-catenin is 
phosphorylated by GSK3ǃ. The phosphorylated ǃ-catenin in turn is recognized by the 
ubiquitin ligase ǃ-TrCP, which targets it for ubiquitin-mediated proteosomal degradation 
(Weeraratna, 2005). The canonical Wnt signaling is initiated by simultaneous binding of the 
Wnt ligand both to Fz receptor and LRP-5/6 coreceptor (Tamai et al., 2000). The ternary 
complex formation recruits a group of proteins including Disheveled (Dvl), Axin and 
GSK3ǃ to the plasma membrane, where they form the Lrp6 signalosomes (Bilic et al., 2007). 
Aggregation causes CK1Ǆ and GSK3ǃ-mediated LRP6 phosphorylation. According to the 
modern view, the cytoplasmic scaffolding protein Dvl is required for the LRP6 aggregation 
and phosphorylation (Niehrs & Shen, 2010). Wnt-stimulated Dvl becomes hyper-
phosphorylated and forms polymers that are recruited to the plasma membrane, providing 
a platform for the Axin-GSK3ǃ relocation (Cliffe et al., 2003). This relocation in turn results 
in inhibition of the ǃ-catenin phosphorylation and further signaling transduction (Mao et al., 
2001). The ǃ-catenin stabilization is a key event in activation of the canonical Wnt signaling. 
The stabilized ǃ-catenin accumulates in the cytoplasm, translocates into the nucleus and 
participates in target gene regulation. ǃ-catenin by itself is unable to bind DNA, but it can 
induce transcriptional activity of Tcf/Lef1 (Behrens et al., 1996). In the absence of ǃ-catenin, 
Tcf/Lef1 acts as a transcriptional repressor. It can bind to the consensus motif 
(A/T)(A/T)CAA(A/T)G on DNA but has no trans-activation domain to induce 
transcription. In the ǃ-catenin/Tcf/Lef1 complex, Tcf/Lef1 facilitates DNA-binding whereas 
ǃ-catenin provides transactivation domains (Brantjes et al., 2002). 
2.1.2 The noncanonical Wnt signaling pathways 
At least two additional signaling pathways activated by Wnt ligands have been identified: 
the Wnt/Ca2+ pathway and the PCP pathway. Both of them are ǃ-catenin-independent and 
are referred to as the noncanonical signaling pathways. Similar to the ǃ-catenin signaling, 
the noncanonical pathways are essential for embryogenesis. They regulate multiple 
morphogenetic processes including gastrulation and neural tube closure (Jenny & Mlodzik, 
2006; Kohn & Moon, 2005). 
2.1.2.1 The Wnt/Ca2+ pathway 
The Wnt/Ca2+ pathway includes calcium release from the intracellular stores and induction 
of enzymatic activity of Ca2+-dependent protein kinases like calmodulin kinases, protein 
kinase C (PKC) and calcineurin (Kohn & Moon, 2005). The first ligand identified to induce 
transient spikes of the intracellular calcium is Wnt5a. In Xenopus embryos, it was shown that 
Wnt5a expression blocked the ability of the canonical Wnt8 to induce axis duplication. 
These data confirmed an idea of existence of multiple Wnt signaling pathways. The more 
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precise data came from studies in Xenopus and zebrafish models. It was revealed that Wnt5a 
overexpression phenocopied overexpression of a serpentine receptor that stimulates the 
intracellular calcium release in a G-protein-dependent manner. Later, an appropriate Fz 
receptor Rfz-2 was identified (Kuhl et al., 2000). The Wnt coupling to receptor (Fz, Rfz2) 
leads to dissociation of the Gǂ and Gǃ/Ǆ subunits. Gǃ/Ǆ activates phospholipase C (PLC), 
which translocates to the membrane and hydrolyzes phosphotidylinositol 4,5- biphosphate 
(PIP2) into inositol 1,4,5- triphosphate (IP3) and di-acyl glycerol (DAG). DAG activates PKC, 
while IP3 induces Ca2+ release from the intracellular stores. Elevation of the intracellular 
calcium level in turn stimulates the Ca2+-dependent effector molecules. Reminiscent of the 
canonical Wnt signaling-mediated Dvl translocation, Wnt5a expression results in PKC 
translocation to the plasma membrane where it is able to interact with its target proteins 
(Weeraratna, 2005). There is a positive feedback loop between PKC and Wnt5a. Inhibition of 
PKC can result in decrease of Wnt5a expression, whereas PKC activation leads to Wnt5a 
upregulation (Jonsson et al., 1998). Signaling cascades activated by PKC affect cytoskeletal 
organization and cell motility. 
2.1.2.2 The Planar Cell Polarity pathway 
Another noncanonical Wnt signaling pathway is the Planar Cell Polarity, or PCP, pathway. It 
was initially discovered in Drosophila melanogaster, but later found to control some critical 
biological processes in vertebrates (Mlodzik, 2002; Wang & Nathans, 2007). Polarity is an 
important feature in living organisms, underlying the proper performance of many functions. 
There are several kinds of polarity. Epithelial cells are polarized in two different manners. 
Besides apical-basal polarity, they also display polarization along the plane of the epithelial 
layer orthogonal to the apical-basal axis. This kind of polarization is called tissue polarity, or 
planar cell polarity (PCP). It is notable that, besides the epithelial cell polarity, the PCP 
proteins also provide mesenchymal cell intercalation during axis elongation process in 
vertebrates (Xenopus and zebrafish). The principal mechanism for tissue elongation is an 
insertion of mesenchymal cells between their neighbors along one axis. In this case, the 
mesenchymal cells have no apical-basal polarity but are able to extend polarized protrusions 
in the same direction. Thus, these cells are oriented with respect to direction of movement 
(Zallen, 2007). The transmembrane PCP proteins Frizzled, Strabismus, and Flamingo and the 
cytoplasmic PCP proteins Dvl and Prickle are critical for proper intercalation (Keller, 2002; 
Myers et al., 2002; Wallingford et al., 2002). Reestablishing of cell polarity after a mitotic cell 
division is also dependent on the PCP pathway (Nechiporuk & Vasioukhin, 2006). The 
Wnt/PCP pathway controls activity of the small GTPases Rho and Rac. The Rho signaling 
branch requires activation of the Dvl-Daam-1 (Dishevelled-associated activator of 
morphogenesis 1) complex and results in the Rho-associated kinase (ROCK) and myosin 
activation (Habas et al., 2001; Marlow et al., 2002; Weiser et al., 2007). Daam-1 is a member of 
the Formin protein family. It mediates an assembly of the Dvl-RhoA complex acting as a 
scaffolding protein (Habas et al., 2001). The Rac branch of signaling is Daam-1-independent. It 
requires another domain of Dvl to induce activity of small Rac GTPase. Activated Rac in turn 
stimulates Jun kinase (JNK) (Habas et al., 2003; Li et al., 1999). The PCP pathway regulates 
modifications of actin cytoskeleton structures and, as a consequence, provides cytoskeletal 
rearrangements and directed migration. In addition, it is considered that, unlike to the above 
mentioned pathways, the PCP cascade appears to function independently of transcription.  
Actually, the majority of molecular cascades connected with Rho/Rac GTPases and PKC 
mostly affect cell motility. This observation allows to suggest that the noncanonical Wnt 
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signaling branches are implicated exactly in these processes. Contrariwise, the canonical 
Wnt signaling controls predominately proliferation and differentiation acting at a 
transcriptional level. 
2.2 Wnt signaling in skin biology 
In embryogenesis, components of the Wnt cascade are involved in multiple processes 
including neural crest induction, specification and differentiation (Dorsky et al., 1998). 
Neural crest cells arise from a region called neural folds at the border of the neural plate and 
non-neural ectoderm. During neurulation, neural folds converge at the dorsal midline of an 
embryo to form the neural tube. According to the conventional view, this process is 
mediated by molecular signals emanating from the ectoderm and receiving by the 
neuroepithelium. Numerous experiments in amphibian, zebrafish, avian and murine 
embryos revealed Wnt signaling as a driving force in this process (Garćia-Castro et al., 2002; 
Huang & Saint-Jeannet, 2004; Lewis et al., 2004). Depletion of the main effector component 
of the canonical Wnt signaling, ǃ-catenin, abrogates the neural crest induction (Wu et al., 
2005), and the promoter region of neural crest-specific gene Slug contains a binding site for 
Lef/ǃ-catenin complex (Vallin et al., 2001).  
The fate of the neural crest cells is also under control of the Wnt signaling pathway. Some 
reports confirm that Wnt6 and Wnt8 are required both for the neural crest induction and its 
expansion (Labonne & Bronner-Fraser, 1998; Sakai et al., 2005). After neurulation, neural 
crest cells from the roof plate of the neural tube undergo an epithelial-to-mesenchymal 
transition and migrate to the peripheral sites. This migration is an elaborate process, tightly 
controlled on a molecular level. It is believed that, unlike to the neural crest induction 
controlled by the canonical Wnt signaling, migration of neural crest cells mostly depends on 
another kind of the Wnt signaling called the noncanonical or the Planar Cell Polarity (PCP). 
Inhibition of the PCP factors like Wnt11, Frizzled7 (Fz7) and Dishevelled (Dvl) results in a 
failure of the neural crest cells migration, indicating that the noncanonical Wnt signaling is 
essential for the neural crest migration in vivo (De Calisto et al., 2005). 
The neural crest cells give rise to diverse cell types, including neurons, glia and 
melanocytes. Neurogenic and melanogenic populations of the neural crest cells have distinct 
migratory specificities governed by expression of different surface receptors and signaling 
moleculars, including Wnts (Thomas & Erickson, 2008). The Wnt signaling is supposed to be 
important for the neural crest cells specification. Neuroblasts and glioblasts show strong 
expression of the Wnt signaling inhibitor protein called Frzb-1. Conversely, the Frzb-1 
expression level in melanoblasts is decreased (Jin et al., 2001). Other evidence of the Wnt 
signaling participation in the neural crest cells specification comes from knockout studies. 
The Wnt1 and Wnt3a double-knockout mice exhibit defects in the neural crest cell 
derivatives, including melanocytes (Ikeya et al., 1997). The ǃ-catenin knockout in the neural 
crest cells leads to loss of both melanocytes and sensory neurons (Hari et al., 2002). In the 
presence of Wnt3a in conditioned medium, the cultured quail neural crest cells evolve into 
melanoblasts (Jin et al., 2001). Injection of mRNA encoding cytoplasmic ǃ-catenin into the 
neural crest cells of a zebrafish embryo targets them to a pigment cell fate at the expense of 
neurons and glia (Dorsky et al., 1998). In melanocytes, the canonical ligand Wnt3a promotes 
up-regulation of the microphthalmia-associated transcription factor (MITF), the master 
regulator of melanogenesis. The MITF expression starts in melanoblasts soon after their 
migration from the neural tube, and loss of MITF results in the absence of melanocytes 
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(Thomas & Erickson, 2009). Interestingly, the MITF expression is abolished in the fibroblasts 
derived from skin treated with the Wnt signaling inhibitor Dkk-1. Along with the MITF 
inhibition, these samples also show the decreased ǃ-catenin expression level. Dkk-1 is 
supposed to be a key molecular determinant for a regional specificity in human skin 
pigmentation. Hands and feet express Dkk-1 at a higher level comparing to a trunk, and are 
less pigmented due to a lower melanocyte density. It is believed that in epidermis Dkk-1 
inhibits both melanocyte differentiation and melanin production (Yamaguchi et al., 2007). 
The terminal cell differentiation can be inhibited in a ǃ-catenin-independent manner. A way 
to keep cells in a precursor state is provided by a member of the Tcf/Lef family, Tcf-3, that 
acts as a repressor of the Wnt-mediated transcription. Tcf-3 is normally expressed in the hair 
follicle bulge and basal layer of the outer root sheath. Ectopic expression of Tcf-3 in 
interfollicular epidermis inhibits terminal keratinocytes differentiation and induces a shift to 
progenitor-like molecular phenotype (Nguyen et al., 2006). The noncanonical Wnt signaling 
activated by Wnt5a also can antagonize the canonical signaling and inhibit expression of 
melanogenic antigens (Dissanayake et al., 2008). This observation leads to an idea that, 
whereas the canonical Wnt signaling is important for melanoblasts positioning and 
differentiation, the other Wnt signaling type serves for maintenance of the de-differentiated 
cell state. The idea is supported by data from the hematopoetic stem cells (HSCs). These 
cells are maintained in a quiescent state by Wnt5a, and the canonical Wnt signaling, 
contrariwise, makes them differentiate (Nemeth et al., 2007). The melanocyte stem cells 
express receptors for the Wnt signaling pathway on their surfaces (Yamada et al., 2010). 
Taking into account these data and the data from melanocytes regulation, it was speculated 
that Wnt5a could be involved in the quiescence maintenance of the melanocyte stem cells 
(MSCs), keeping them in their niche environment (Nishikawa & Osawa, 2007; O’Connell & 
Weeraratna, 2009). Stem cells committed to the melanocyte lineage reside in the bulge area 
of hair follicles (Nishimura et al., 2002). Being a source of melanoblasts and melanocytes, in 
adults they are most likely to be related to hyperpigmentation and age-associated hair 
graying (Yamada et al., 2010). 
Mammalian skin serves many critical biological functions to maintain homeostasis. 
Evidence indicates that the Wnt signaling is implicated in this process. The protective 
function of skin can be disturbed by wounding. The only way to restore skin integrity and, 
as a result, its protective function is healing of the wound. Unfortunately, wound healing 
and true regeneration are not the same. Cutaneous repair after the loss of full-thickness skin 
usually leads to scarring. The healed tissue contains a collagen-rich dermal matrix with a 
stratified epithelial covering. It is less elastic, has a lower tensile strength level and unable to 
form skin appendages. Interestingly, skin actually has a potential to regenerate, since it 
contains the multipotent epidermal stem cells in hair follicles and the undifferentiated 
mesenchymal cells in the dermis. Thus, it is postulated that scar repairing is more favorable 
than regeneration due to molecular context in the affected area. It is considered that the Wnt 
signaling pathway contributes significantly to this molecular context. To elucidate the role 
of the Wnt signaling in wound healing, the Wnt expression is examined at various times 
after wounding. Wnt-4 is expressed early in the process, while Wnt-5a and Wnt-11 
expression peaks are at the time of wound remodeling. The "TOPGAL" mice experiments 
reveal that the canonical Wnt signaling activity is increased in the hair follicles adjacent to 
the lesion, but not within the wound or overlying epithelium. Furthermore, the stabilized ǃ-
catenin expression results in epithelial appendages formation like hair follicles and sebaceous 
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glands within the wound (Fathke et al., 2006). The rate of wound closure is not affected by the 
ǃ-catenin expression. Interestingly, the TGFǃ-induced wound healing is partially regulated by 
ǃ-catenin. Expression of Mmp-3 and Mmp-14 stimulated by TGFǃ requires the ǃ-catenin 
expression (Cheon et al., 2005). The noncanonical Wnt signaling is also able to direct adult skin 
progenitor cells toward regeneration. Wound transduction with the retrovirus expressing the 
typical noncanonical Wnt ligand Wnt-5a leads to even more abundant epithelial appendage 
formation in the wound, as compared with the stabilized ǃ-catenin expression. Moreover, the 
authors report that the noncanonical Wnt signaling activation in epidermis is not associated 
with epithelial tumors, in contrast to the ǃ-catenin-dependent signaling whose activation 
sometimes results in tumor formation (Fathke et al., 2006). 
Skin development and homeostasis are considerably dependent on regulation by the Wnt 
signaling. It is implicated in the neural crest induction and specification, determining of 
epidermal and melanocyte stem cells fate, hair follicle establishment and entry of its cells into 
the active growth phase and wound healing. Considering significance of the Wnt signaling in 
skin biology, it is not surprising that its malfunctions are often seen in different pathological 
conditions. Expression pattern of many Wnts is affected in malignant melanoma. 
2.3 Wnt signaling in melanoma 
Aberrant activation of the Wnt signaling pathways is often observed in melanoma. The 
cutaneous melanoma is considered as a neural crest-derived malignancy. It originates from 
the melanocyte progenitor cells or from the pigment-producing melanocytes. Taking into 
account that the Wnt signaling cascades play a crucial role in the neural crest induction, 
specification and melanocyte differentiation, implication of the different Wnt signaling 
branches in melanoma pathogenesis seems quite natural. 
The cutaneous melanoma is a common skin cancer characterized by high aggressiveness, 
morbidity and mortality. The melanoma development is a multistep process. It includes a 
congenital or acquired nevus, a dysplastic atypical nevus, a radial growth phase (RGP) 
melanoma, a vertical growth phase (VGP) melanoma and a metastatic melanoma (Larue & 
Beermann, 2007). Uncontrolled cell proliferation leads to the mole formation. It is considered 
that further immortalization is required for melanoma induction (Larue et al., 2009). A 
fraction of atypical nevi undergoes malignant transformation into a RGP melanoma with 
low probability to metastasize. Unlike to RGP, a VGP melanoma has high invasive and 
metastatic capabilities. A metastatic melanoma is usually resistant to chemotherapy and 
radiation (Govindarajan et al., 2007). It is believed that components of the Wnt signaling 
cascades can contribute to all stages of melanoma progression. There are several hypotheses 
describing potential roles of the canonical and noncanonical Wnt signaling branches in 
melanomagenesis. Thus, according to one of them, aberrations in the canonical signaling 
lead to melanoma formation, whereas the noncanonical Wnt signaling malfunctions are 
associated with metastatic progression. Furthermore, during melanoma progression, the ǃ-
catenin signaling serves as a negative regulator of tumor growth. Numerous data confirms 
this idea. However, it is worth mentioning that some researchers argue against this 
conception. They consider the canonical Wnt signaling as a fully oncogenic. Anyway, the 
Wnt signaling is somehow implicated in melanoma progression. In the case of melanoma, 
Wnt1, Wnt3a and Wnt5a are best described. Wnt1 and Wnt3a are considered as the 
canonical ligands and Wnt5a as an activator of the Wnt/Ca2+ pathway. 
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2.3.1 Implication of the canonical Wnt signaling in melanoma cell fate 
In normal skin, melanocytes are interspersed among keratinocytes at the epidermal-dermal 
border. Physical and functional interaction with keratinocytes provides control of 
melanocyte proliferation and differentiation. In the absence of this control, melanocytes tend 
to rapid proliferation and expression of cell surface molecules normally associated with 
melanoma (McGary et al., 2002). A transmembrane protein E-cadherin is considered as the 
major mediator of human melanocyte adhesion to keratinocytes. Loss of E-cadherin is often 
associated with tumorigenesis including melanoma (Haass et al., 2005). Interestingly, E-
cadherin does not only act as a cell-cell adhesion molecule, but also mediates intracellular 
signaling through ǃ-catenin. Indeed, ǃ-catenin was originally identified as an interlink 
between E-cadherin and ǂ-catenin in the adherens junctions (Cowin, 1994; Gumbiner & 
Neuron, 1993; Nagafuchi & Takeichi, 1989; Ozawa et al., 1989). Downregulation of E-
cadherin leads to release of ǃ-catenin from the membrane-associated pool and to increase of 
its transcriptional activity. The activated canonical Wnt signaling is found in approximately 
one third of melanomas (Larue et al., 2009). Keeping in mind that the ǃ-catenin signaling 
promotes expression of many "growth" genes, including cyclin D and c-myc, constitutive 
activation of this cascade can potentially stimulate tumor formation. For example, c-myc is a 
well-known oncogene. Its overexpression is found in a variety of human cancers including 
colorectal cancer, breast cancer, leukemia and melanoma (Dang, 1999). Inhibition of c-myc is 
supposed to be an important step in tumor growth restriction. Supporting this idea, the c-
myc antisense oligonucleotides have been shown to decrease proliferation of different cancer 
cells (Iversen et al., 2003). 
Expression of the canonical Wnt signaling negative regulators is often reduced in 
melanoma. Thus, Dkk-1, -2 and -3 are downregulated or lost both in melanoma cell lines 
and tumor samples (Kuphal et al., 2006). Dkk-1 and Dkk-2 inhibit the ǃ-catenin signaling by 
binding to LRP5/6 coreceptor. It has been shown that Dkk-1 can suppress melanocyte 
growth and melanogenesis (Yamaguchi et al., 2004). Activation of the Dkk-1 expression 
results in inhibition of tumorigenicity and induction of apoptosis in melanoma cells during 
in vivo growth in the athymic nude mice (Mikheev et al., 2007). Another Wnt signaling 
inhibitor repressed in melanoma is WIF-1 (Wnt inhibitory factor-1) (Haqq et al., 2005). 
Unlike to Dkk, WIF-1 binds directly to the Wnt ligand blocking its signaling activity. 
Unfortunately, it remains unknown, which type of the Wnt signaling is inhibited by WIF-1. 
Anyway, the WIF-1 silencing may be a critical event in constitutive activation of the 
canonical Wnt pathway in melanoma cells. It is reported that melanoma cell growth is 
suppressed by WIF-1 overexpression, and the suppression is related to transcriptional and 
translational inhibition of the canonical Wnt signaling components, including ǃ-catenin, 
Dvl-3, and cyclin D1 (Lin et al., 2007). 
Besides extracellular inhibitors of the canonical Wnt signaling, like Dkk and WIF-1, 
expression of the cytoplasmic CK1ǂ in melanoma is frequently decreased or completely lost. 
CK1ǂ is responsible for initial phosphorylation of ǃ-catenin that is required for the GSK3ǃ-
mediated ǃ-catenin degradation (Liu et al., 2002). CK1ǂ expression in invasive melanoma 
cells decreases growth rate and induces cell cycle arrest and apoptosis, whereas suppression 
of CK1ǂ in primary melanomas has an opposite effect. Evidence confirming ǃ-catenin 
implication in this effect comes from the ǃ-catenin downregulation experiments. Inhibition 
of the ǃ-catenin expression in the nonmetastatic melanoma cell lines results in inhibition of 
invasive growth (Sinnberg et al., 2010). 
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As mentioned above, ǃ-catenin is a multifunctional protein, and its function is supposed to 
depend on cellular localization. At the membrane, ǃ-catenin is a component of the cadherin 
adherens junctions and in the nucleus it acts as a transcriptional activator of the canonical 
Wnt signaling target genes. There are several reports that ǃ-catenin is accumulated in the 
cytoplasm or nucleus of human melanoma cell lines and original tumors (Rubinfeld et al., 
1997). But unlike to other cancers, the elevated level of ǃ-catenin in melanoma is rarely 
associated with mutations (Giles et al., 2003). Melanoma is very heterogeneous. The activity 
and regulation of the canonical Wnt signaling vary significantly among different patients. 
Nuclear ǃ-catenin localization is not always sufficient for the canonical Wnt signaling 
activation.  Several cell lines with high nuclear ǃ-catenin level are unable to activate this 
signaling (Kulikova et al., in press). 
According to some notions, ǃ-catenin can induce melanocyte immortalization by bypassing 
the senescence barrier (Delmas et al., 2007). A growth arrest after a limited number of 
divisions represents a good way to protect cells from oncogenic transformation (Campisi, 
2005). Uncontrolled proliferation and delayed senescence are considered to be enough for 
melanoma transformation. Activating mutations in N-Ras and B-Raf (the MAP-kinase 
signaling pathway) can provide signals for proliferation, whereas ǃ-catenin is believed to 
contribute to senescence escape (Delmas et al., 2007; Gray-Schopfer et al., 2005; Tsao et al., 
2000). Senescence is associated with the G0/G1-like cell cycle arrest induced by the tumor 
suppressor Rb1 that in turn is controlled by p16INK4a (Narita et al., 2003). In melanoma, the 
p16INK4a expression is often silenced by genetic and epigenetic mechanisms. It has been 
shown that in transgenic mice, the stabilized ǃ-catenin decreases a number of melanoblasts 
and stimulates immortalization of primary skin melanocytes by silencing the p16INK4a 
promoter (Delmas et al., 2007). Transgenic animals expressing the stabilized form of ǃ-
catenin demonstrate an elevated ǃ-catenin level in the nucleus of target cells that mimics the 
constitutively active ǃ-catenin in melanomas. Moreover, in human melanoma cells, this 
activated ǃ-catenin represses p16INK4a directly in a TCF4-dependent manner. It should be 
noted that ǃ-catenin by itself is unable to induce either melanocyte proliferation or 
melanoma formation. However, the double transgenic animals carrying both N-Ras and ǃ-
catenin mutations show a high rate of melanoma incidences. Moreover, these double 
mutants are more subject to melanomagenesis than the single N-Ras transgenic mice. Thus, 
it has been postulated that the constitutively activated canonical Wnt signaling acts 
synergistically with the MAP kinase pathways in order to induce melanoma in the absence 
of the p16INK4a mutation (Delmas et al., 2007). 
The MAP kinase and ǃ-catenin signaling cascades regulate activity of the master regulator 
of melanogenesis, MITF-M. In melanoma characterized by simultaneous activation of N-Ras 
and ǃ-catenin, the MITF level is higher than in N-Ras-driven tumors (Larue et al., 2009). 
MITF-M regulates a wide range of biological processes including cell proliferation and 
differentiation (Palmieri et al., 2009). According to the current hypothesis, the ǃ-catenin 
capacity to activate MITF-M underlies its ability to regulate the melanocyte number 
(Widlund et al., 2002; Larue & Delmas, 2006; Schepsky et al., 2006). A high level of MITF 
activity restricts cell division, whereas a low level is associated with proliferation (Carreira 
et al., 2005, 2006; Loercher et al., 2005; Wellbrock & Marais, 2005). Thus, ǃ-catenin, being a 
direct regulator of the MITF-M expression, can affect melanocyte proliferation. In case of the 
ǃ-catenin transgenic mice, the overactivated canonical Wnt signaling can lead to MITF 
activation and restriction of melanoblast proliferation. 
www.intechopen.com
 
Dual Function of Wnts in Human Cutaneous Melanoma 
 
253 
In spite of numerous studies confirming the ǃ-catenin implication in malignant 
transformation of melanocytes, the exact role of the Wnt/ǃ-catenin signaling in melanoma 
and especially in melanoma metastasis remains quite controversial. Whereas a lot of papers 
claim that ǃ-catenin is not associated with melanoma progression (not transformation), there 
is a report revealing a form of ǃ-catenin that does correlate to the disease stage. Surprisingly, 
this phosphorylated form of ǃ-catenin in human melanoma bioptic samples is accumulated 
in nucleus. However, as far as we know, the phosphorylated ǃ-catenin is usually targeted 
for degradation in the cytoplasm (Kielhorn et al., 2003). Moreover, in contrast to the results 
from transgenic mice revealing no activation of proliferation in response to the stabilized ǃ-
catenin, in human melanoma cell lines ǃ-catenin induced melanoma growth mediated by 
the MITF upregulation (Widlund et al., 2002). On the other hand, a lot of data demonstrate 
that the ǃ-catenin signaling actually acts as a negative regulator of melanoma progression. 
Almost all benign nevi are positive for the nuclear ǃ-catenin, but the rate of nevi 
transformation into melanoma is very low (Tsao et al., 2003). Metastatic melanoma 
progression is associated with a loss of the nuclear ǃ-catenin. Contrariwise, the nuclear 
accumulation of ǃ-catenin is a good sign for patients (Bachmann et al., 2005; Chien et al., 
2009; Kageshita et al., 2001; Maelandsmo et al., 2003). The canonical Wnt signaling plays a 
crucial role in the pigment cell biology (Fang D et al., 2006). Wnt3a and Wnt1 are factors 
required for differentiation of pluripotent stem cells into functional melanocytes (Dorsky et 
al., 1998). Treatment of melanoma cells with Wnt3a results in increased pigmentation, 
transcriptional upregulation of melanogenic antigens and decreased metastatic ability 
(Chien et al., 2009). The Wnt3a-upregulated melanogenic antigens, including Trpm1, Kit, 
Met, and Mlana, are normally associated with melanocyte differentiation. They are 
frequently lost during metastatic tumor progression (Ryu et al., 2007). Transfection of the 
B16 melanoma cells with Wnt3a leads to decreased proliferation and induces differentiation 
(Chien et al., 2009). Moreover, silencing of ǃ-catenin in this cell line actually promotes 
metastasis (Takahashi et al., 2008). Inhibition of negative regulators of the canonical Wnt 
signaling has a similar effect. The GSK3ǃ suppression increases melanogenesis both in the 
B16 cells and melanocytes and decreases proliferation of the cultured B16 and human 
melanoma cells (Bellei et al., 2008; Chien et al., 2009). 
Thus, the canonical Wnt signaling pathway seems to play a dual role in melanomagenesis, 
depending on the context. On the one hand, it can somehow contribute to melanocyte 
transformation, and on the other, it can restrain tumor progression. Taking into 
consideration all these observations, it is possible that the Wnt/ǃ-catenin signaling may be 
required to maintain a homeostasis (Lucero et al., 2010). The dysregulation of specific 
transcriptional programs in melanocytes or nevi can lead to early melanoma transformation. 
2.3.2 Contribution of the noncanonical Wnt signaling to melanoma metastasis 
Regarding the noncanonical Wnt cascades in melanoma, almost all data available at the 
moment is related to the Wnt5a and Wnt/Ca2+-signaling pathway. It is likely that  
Wnt/Ca2+-pathway is not implicated in melanocyte transformation, but rather contributes to 
melanoma progression. The Wnt5a overexpression is frequently observed in highly 
aggressive melanomas (Bittner et al., 2000; Dissanayake et al., 2007; Weeraratna et al., 2002). 
There is a positive correlation between its expression and a tumour stage (Weeraratna et al., 
2002). Moreover, Wnt5a was identified as a good criterion for melanoma division into 
highly aggressive tumors and less invasive counterparts (Bittner et al., 2000). Transfection of 
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less aggressive melanoma cells with Wnt5a converts them into more metastatic derivates. 
Moreover, in melanoma, Wnt5a is predominantly presented at the leading edge of invasion. 
It is considered that the conversion is connected with the PKC activation (Weeraratna et al., 
2002). The PKC signaling is often associated with alterations in cell motility, invasion and 
metastasis. Wnt5a can promote melanoma progression via the PKC-mediated mechanisms 
(Mapelli et al., 1994; Weeraratna et al., 2002). Another possible mechanism that can underlie 
the Wnt5a-dependent metastasis is the PCP pathway. Wnt5a, as well as Wnt1 and Wnt11, 
has been shown to activate the PCP pathway. Key components of this cascade, Rac, Rho and 
Cdc42, participate in melanoma metastasis (Choi & Han, 2002; Clark et al., 2000; Nakahara 
et al., 2003). But, unfortunately, there is no direct evidence supporting this idea. 
The Wnt5a signaling can antagonize the ǃ-catenin signaling (Topol et al., 2003). As it was 
discussed before, silencing of the ǃ-catenin signaling in melanoma cells actually promotes 
metastasis (Takahashi et al., 2008). Taken together, these observations provide a model 
where melanoma metastasis is at least partially associated with the Wnt5a-mediated 
repression of the ǃ-catenin signaling. Notably, treatment of melanocytes with Wnt5a can 
induce their apoptosis but not transformation (O’Connell & Weeraratna, 2009). However, in 
melanoma, the Wnt5a-mediated increase in CamKII phosphorylation has been shown to 
protect cells against the Trail-induced apoptosis (Dissanayake et al., 2007; Xiao et al., 2005). 
Considering the tumor suppressor role of Wnt5a in other cancers, it is easy to speculate that 
a cellular context may be very important for the Wnt5a response determination. Moreover, 
balance between the canonical and noncanonical Wnt signaling pathways may be crucial for 
homeostasis maintenance (O’Connell & Weeraratna, 2009). In benign nevi, Wnt5a may 
prevent the ǃ-catenin-dependent melanocyte transformation; in melanoma progression, the 
canonical Wnt signaling may inhibit the Wnt5a-driven metastasis. The opposite is true for 
melanomagenesis. The aberrantly activated canonical Wnt signaling is important for 
melanoma establishment, and, during cancer progression, it should be inhibited by the 
Wnt5a signaling in order to keep melanoma cells undifferentiated. 
Expression of Wnt5a in the nevi is quite controversial. While some researchers argue against 
the Wnt5a expression in the majority of benign nevi, others report the relatively strong 
Wnt5a expression (Da Forno et al., 2008; Mapelli et al., 1994; Pham et al., 2003). However, 
this disagreement can be explained by different sensitivity of methods used for Wnt5a 
detection. Considering high motility of the nevus cells and association of Wnt5a with 
decreased proliferation, the observation of a high Wnt5a level in the nevi is quite 
conforming to the behavior of these cells. 
Multiple data confirms that Wnt5a mediates its effects via the PKC activation (Dissanayake 
et al., 2007). In order to activate the noncanonical Wnt signaling in melanoma cells, Wnt5a 
must bind to a specific cohort of receptors, including Fz2, Fz5 and Ror2 (Billiard et al., 2005; 
Weeraratna et al., 2002). Treatment of melanoma cells with an antibody against Fz5 leads to 
inhibition of the PKC activation, reduced motility and invasion of melanoma cells (Sen et al., 
2001, Weeraratna et al., 2002). But the major Wnt5a receptor implicated in melanoma 
metastasis is supposed to be Ror2 (O’Connell et al., 2010). Like Wnt5a, it is upregulated 
predominantly in metastatic melanomas and has a negative correlation with melanoma 
patients survival (O’Connell et al., 2010). A knockdown of this receptor abrogates ability of 
Wnt5a to signal and mediate metastasis. Interestingly, overexpression or silencing of Wnt5a 
increases or decreases level of Ror2, respectively. However, downregulation of Ror2 has no 
effect on the Wnt5a expression (O’Connell et al., 2010). 
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Wnt5a can promote melanoma metastasis via different cellular mechanisms. First of all, it 
can induce morphological changes of melanoma cells. There is a report showing that 
transfection of melanoma cells (derived from an axillary lymph node) with the low 
endogenous Wnt5a expression with the Wnt5a-coding plasmid leads to shift from compact 
and roughly triangular cell shape into thin and spreading morphology. Cell shape changes 
were accompanied by increase in a number of contacts with the substrate (increased 
adhesion), actin cytoskeleton reorganization and PKC activation. Moreover, the transfected 
cells were more motile, as compared with the parent cells. Interestingly, the most affected 
PKC isoforms in the Wnt5a-transfected cells were PKCµ and PKCǃII, that are considered to 
participate in cytoskeletal organization and invasion, respectively (Weeraratna et al., 2002).  
Morphological changes induced by the Wnt5a overexpression remind characteristics of the 
mesenchymal phenotype. Actually, cells with similar features are observed in many cancers. 
Mesenchymal motility is characterized by polarized and elongated cell morphology. It 
requires degradation of extracellular matrix (ECM) components in order to generate a "path" 
for moving cells (Parri et al., 2009). Wnt5a is considered to promote exactly this form of 
invasion. Thus, the Wnt5a overexpression stimulates production of matrix 
metalloproteinases like MMP-2 and MMP7 that degrade ECM (O’Connell et al., 2008; 
Pukrop et al., 2006). It also induces a shift in expression of cadherins, from E-cadherins to N-
cadherins (Hsu et al., 2002). This shift decreases cell-to-cell contacts and facilitates cell-to-
ECM interactions. Notably, Wnt5a also increases a level of an intermediate filament protein 
called vimentin and up-regulates expression of the transcriptional factor Snail, which are 
typical components of the mesenchymal cells. Wnt5a mediates its action on vimentin and 
Snail levels via the PKC activation (Dissanayake et al., 2007). Snail is a transcription factor 
capable of reducing the E-cadherin expression by binding to E-box elements in the cadherin 
promoter (Batlle et al., 2000). There is a positive feedback between Wnt5a and PKC. Wnt5a 
induces production of PKC, and vice versa (Jonsson et al., 1998). Thus, on the one hand, 
Wnt5a is able to support its own expression level, and on the other, it can affect cell motility 
through induction of the Snail-mediated E-cadherin repression.  
Besides the N-cadherin and vimentin expression, Wnt5a also stimulates expression of the 
glycosaminoglycan hyaluronan receptor CD44, a tumor cell homing and metastasis-
associated gene, and inhibits expression of the metastasis suppressor of melanoma KISS-1 
(Dissanayake et al., 2007). CD44 is a promigratory factor. In vitro study reveals its ability to 
enhance melanoma cell invasion in collagen gel (Albini, 1998). Inhibition of the Wnt5a-
induced PKC activation significantly reduces the CD44 expression (Dissanayake et al., 2007). 
Recently it has been shown that Wnt5a can increase the calpain protease-mediated cleavage of 
the cytoskeletal protein filamin. In the migratory osteoblast cells, filamin can induce filopodia 
formation. Overexpression of filamin is frequently observed in highly metastatic melanomas. 
In these cells filamin is distributed in a diffuse manner. Its cleavage is associated with 
enhanced cell motility (Nomachi et al., 2008; O’Connell et al., 2009). Inhibition of filamin in 
melanoma decreases cell migration. Calpain is a Ca2+-sensitive protein. Thus, Wnt5a promotes 
melanoma metastasis by induction of Ca2+ release and subsequent activation of calpain and 
calpain-mediated filamin cleavage (O’Connell et al., 2009). 
Another mechanism underlying melanoma metastasis is associated with alterations in cell 
adhesion. In the case of melanoma, adhesion predicts a less favorable outcome for patients. 
Many cell adhesion molecules are upregulated during tumor progression (O’Connell & 
Weeraratna, 2009). There is a notion explaining a positive correlation between enhanced 
adhesion and invasion. It is considered that for efficient tumor dissemination cancer cells 
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must bind to endothelial cells (Albini, 1998; Cardones et al., 2003). Activated endothelial 
cells expose numerous adhesion molecules (VCAM-1, ICAM-1, E-selectin) on their surfaces 
(Chirivi et al., 1996). These adhesion molecules present good binding partners for cancer cell 
receptors. Cancer cells can both promote endothelial cells activation by production of IL-1ǂ 
and enhance expression of its receptors for interaction with endothelial cells (Albini, 1998). 
Thus, melanoma is pushed towards invasion by enhanced adhesion. ǃ1 integrins promote 
the CXCR4-mediated interaction between tumor and endothelial cells (Cardones et al., 
2003). And ǂ3ǃ1 integrin has been shown to provide migration and invasion of several 
melanoma cell lines (Melchiori et al., 1995). Wnt5a overexpression can lead to increase in 
substrate adhesion (Weeraratna et al., 2002). Moreover, melanoma cells exposed to the 
CXCL12 chemokine gradient demonstrate redistribution of the melanoma cell adhesion 
molecules (MCAM) into a polarized structure. And this process is controlled by the Wnt5a 
signaling (Witze et al., 2008). 
At last, the Wnt5a signaling has been shown to modulate immunogenicity of melanoma 
cells. The melanoma-associated antigens important for the cytotoxic T lymphocyte (CTL) 
response include MART-1, DCT, TYRP-1 (GP75) and GP100 (SILV). All of them are 
regulated by the transcription factors Sox10, Pax3 and MITF. Wnt5a can decrease 
melanosomal antigen expression by activation of PKC and STAT3 (Dissanayake et al., 2008) 
It is believed that PKC stimulated by Wnt5a is implicated in the STAT3 phosphorylation 
(Gartsbein et al., 2006; Sheldahl et al., 1999). Phosphorylated STAT3 is active and can reduce 
the Pax3 expression (Kamaraju et al., 2002). Inhibition of the Pax3 expression in turn results 
in the MITF repression and subsequent MART-1 silencing. Treatment of melanoma cells 
with phorbol ester has the same effect as the Wnt5a stimulation, and in the presence of 
STAT3 or PKC inhibitors, Wnt5a loses its ability to decrease the MART-1 expression 
(Dissanayake et al., 2008). Ratio of the Wnt5a-positive to the MART-1-negative tumors is 
increasing dramatically in metastasis (Dissanayake et al., 2008). Initially, it was 
demonstrated that melanoma patients could be separated into several cohorts according to 
their Wnt5a and MITF status (Hoek et al., 2006). A cohort with the high Wnt5a and low 
MITF expression has a weak proliferative, but a high metastatic potential. And cohort with 
the low Wnt5a and high MITF demonstrates opposite features: a high ability to proliferate 
and a low ability to metastasize. It is useful to remember that MITF is considered as a target 
of the Wnt/ǃ-catenin signaling. And loss of the nuclear transcriptionally active ǃ-catenin is 
frequently observed at the advanced stages of melanoma. Thus, an opposite correlation 
between the canonical and noncanonical Wnt signaling functions in melanomas can be 
revealed. During metastasis, melanoma cells prefer to downregulate their antigen expression 
in order to escape from immune surveillance of the tumors. The evidence for the notion comes 
from the experiment with MART-1 positive/negative cells presented to cytotoxic T-cells. The 
cytotoxic T-lymphocytes could be activated by melanoma cells expressing MART-1. Treatment 
of these cells with the recombinant Wnt5a abrogates their ability to activate the cytotoxic T-
cells and makes them more resistant to cytolysis. The opposite is also true. Silencing of Wnt5a 
by siRNA in Wnt5a high-leveled cells enhances the MART-1 expression and susceptibility to 
the T-cells-mediated cytolysis (Dissanayake et al., 2008). 
3. Conclusion 
The Wnt signaling pathways compose a really complex network both in melanocytes and in 
melanoma. Multiple receptors, coreceptors, inhibitors and agonists create a cellular context 
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that can vary significantly in benign nevi and tumors. The context determines a kind of a 
response to the Wnt ligand stimulation and gives a key to understanding why the canonical 
and noncanonical Wnt signaling cascades can act both as oncogenic and tumor suppressor 
factors. The Wnt5a and ǃ-catenin signaling cascades play opposite roles in 
melanomagenesis. The canonical Wnt signaling is critical at the early stages of tumor 
development, but in advanced melanoma it serves as a tumor suppressor by promoting 
more differentiated phenotype. The Wnt5a signaling pathway does not participate in 
melanoma formation. On the contrary, it can control the canonical signaling preventing its 
aberrant activation. However, overexpression of Wnt5a is often associated with aggressive 
melanoma phenotype and is believed to promote metastasis. Thus, normally melanocyte 
homeostasis is maintained by tightly regulated system, and aberrations in the system 
regulation result in melanomagenesis. 
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